Personal

Ticket to Biotech

No refunds will be administered. Be sure that you're an accepted T2B member before paying for your ticket.

***If you do not receive your event confirmation within 1 business day of RSVPing (above), check your email spam folder. The automated Luma email includes the Zoom info and cal invite.***

If you're not part of Ticket to Biotech, 

, and join before registering for this event:

COMM CONVO: REACHING AND VALUING EVERY GENERATION

Biopharma communicators' audience has never been more generationally varied, and neither have our teams. We are crafting patient and HCP campaigns for people whose information habits, trusted channels, and decision-making cues look almost nothing alike across age groups, while managing corporate affairs and IR functions where unexamined assumptions and real tensions around ageism, authority, and what experience is actually worth are playing out in real time. And survey data backs this up: nearly 40% of both Baby Boomers and Gen Z workers report having experienced age-based discrimination at work or during their job search (iHire 2025 Multi-Generational Workforce Report). This Comm Convo brings a panel of voices spanning multiple experience levels to share what it takes to reach every stakeholder regardless of their generation, whether they're a patient, an investor, or the person sitting next to you.

​Kelley Dougherty, SVP, Global Head of Corporate Affairs, Teva Pharmaceuticals (Moderator)

 has been leading innovative and collaborative healthcare communication advances for more than 25 years. Kelley is currently SVP, Head of Teva Global Corporate Affairs, following 5 years as VP, North America Communications & Brand at Teva Pharmaceuticals. Previously Global Head of Reputation, Branding and Digital Media at Merck, Kelley had responsibility for enterprise-wide reputation initiatives, global branding and co-leadership of the global enterprise social media and digital efforts for both global communications and marketing. 

Prior to leading North America Communications at Teva, Kelley joined Merck in 1998 to manage the company’s global HIV communications and policy initiatives and held positions of increasing responsibility within global and US-focused communications. Notably, Kelley served as head of communications for Merck’s vaccine business – leading the external launch of four flagship vaccines – led corporate and policy global media relations, forged critical global partnerships and relationships as corporate social responsibility leader and acted as manager of global policy and access. 

Kelley came to Merck with 7 years of unparalleled communications, advertising, medical education and policy experience from her agency work at Nelson Communications (Sciens Worldwide) supporting multiple multi-national pharmaceutical, nutriceutical and consumer goods brands. Kelley received her undergraduate degree from Rowan University.

Mike Kuczkowski, Founder and CEO, Orangefiery

 is the founder and CEO of Orangefiery, a strategy consulting and communications firm. With 30 years of experience in journalism, politics and communications, Mike founded Orangefiery on the principle that strategy and communications are critical to helping organizations navigate today’s dynamic business environment. He is passionate about helping clients solve complex problems with curiosity, rigor and collaboration. 

Mike helps clients adapt and evolve their strategies and communications to drive change. His work with leaders at innovative startups and Fortune 50 companies has helped create new markets, launch new products, fuel business growth and transform organizations. 

A two-time graduate of Syracuse University’s Newhouse School of Communications, Mike holds a bachelor’s in newspaper journalism and a master’s in communications management. Before building Orangefiery, he was an entrepreneur within Edelman—the world’s largest public relations firm—as a first-generation Global Client Relationship Manager, the founding president of Edelman Consulting and lead of the company’s first global team exclusively dedicated to serving a large multinational client with multiple service lines. He has deep experience in healthcare communications, corporate branding, market development, change management and crisis management. He is actively involved in the communications industry, serving as a Trustee of the Institute for Public Relations and on several non-profit boards.

Kyndel McKnight, Corporate Affairs Development Program, AbbVie

 is a participant in AbbVie’s Corporate Affairs Leadership Development Program, where he is gaining experience across rotations within Corporate Affairs and developing his career as a communications professional. A 2025 graduate of Northern Illinois University, Kyndel earned a Bachelor of Arts in Corporate &amp; Organizational Communications and a minor in Journalism.

Catherine Woodwell, Associate Director, Corporate Communications, Mirum Pharmaceuticals

T2B May Comm Convo: Reaching and Valuing Every Generation